ACT

SEPTEMBER 26/2017


Advertisment

news roundup

MHRA Wants Your BREXIT Feedback by Tomorrow

The U.K. Medicines and Healthcare products Regulatory Agency (MHRA) is conducting a survey to better understand how it can support its customers in the run up to the country's exit from European Union.


advertisment

ERT Video Series
Check out the ERT video series, filmed on the show floor at DIA 2017, for interviews on Innovating Clinical Trial Management, eCOA in Clinical Research: Trends and Advances, and Optimizing Clinical Trial Imaging through Advanced Technology.
Click here to watch all 10 short videos


Catalent Invests $5.5 Million in Philly Expansion

Catalent Pharma Solutions is investing $5.5 million at its 200,000+ square foot Philadelphia, PA site to provide additional clinical packaging and storage capacity. The 22,000-square foot expansion will see a 40% increase in pallet space for both refrigerated and ambient storage, the addition of multiple cold chain packaging areas, and a new clinical label control area. All work is scheduled to be completed and validated by November 2017.


advertisment

Tomorrow's Clinical Trial, Powered by Modern EDC
See how to cut study build time in half, eliminate migrations, and remove the need for source data verification (SDV).
See a preview and watch the full webinar here.


Lack of Trust Not a Barrier for Minority Groups in Trials

A recent public opinion survey commissioned by Research!America, found the percentage of respondents citing 'lack of trust' as a reason declined by as much as 15% among minority groups and the population overall.


Survey Pinpoints Data Management Delays Slowing Studies

According to the Tufts—Veeva 2017 eClinical Landscape Study report, it takes companies an average of 68 days to design and release a clinical study database. Delays in releasing the study database lead to increased time for other data management processes, such as patient data entry and time to lock the database at the end of the study.

advertisment

In this edition

Single IRB Review for All Multicenter Clinical Trials
Best Practices for Studies in Rescue
Catalent Invests $5.5 Million in Philly Expansion
RBM—Process Innovation in Clinical Trial Monitoring

Subscribe

Subscribe

Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »


Events

Real-World Evidence
Speed to IND for Biologics
IRT 2017
Search Upcoming Events

advertisment

Rare Diseases and the Eye - Envisioning Strategies for Success
Live Webcast: Friday, October 27 at 11:00am EDT
Register now


Advertisment

Articles

Changes Ahead for EU Device Regulations

The new regulations replace earlier EU directives and add stringent new requirements for CE Marking of new and existing devices. On May 26, 2020, any new medical device certified in the EU must comply with the new requirements of the Medical Device Regulation (MDR). On the same date in 2022, any new in vitro diagnostic device must be certified under the new In Vitro Diagnostic Device Regulation (IVDR).


advertisment

Future-proofing your Pharmacovigilance Delivery Model: Achieving scalability and cost effectiveness with AI/smart machines
Live Webinar: Wednesday, October 25 at 11:00am EDT
Register now


Best Practices for Studies in Rescue

This peer-reviewed article explores how sites tackle enrollment rescue situations, and provides some best practice considerations for how both sponsors and sites can make the most of these circumstances.


advertisment

Proactive Planning, a Transformational Revolution to Improving Clinical Trial Quality?
Live Webcast: Tuesday, September 26, 2017 at 1:00pm EDT
Register now

Blog Posts

Stop Expecting Sites to Love Tech Just Because It's New

As sponsors jumped at the chance to implement new site-facing technologies and processes, they ended up creating a fragmented ecosystem of different software, hardware, vendors, and processes—one or more for each “silo” that exists within the sponsor/CRO world.


advertisment

Clinical Trial Simulation: An Efficient Tool for Improved Study Designs, Dose Selection and Go/No-go Investment Decisions
Live Webcast: Tuesday, September 19 at 2:00pm BST and Thursday, September 28 at 10am EDT
Register now


Single IRB Review for All Multicenter Clinical Trials

Experts make the case for single IRB review for all multicenter trials and encourages sponsors and CROs to limit the choices for review and set the stage for the benefits.


advertisment

Accelerate NASH Development: Next-generation Approaches to Overcome Recruitment and Study Execution Challenges
On Demand
Learn more


Risk-Based Monitoring

Risk-Based Trial Management and Monitoring Conference


Process Innovation in Clinical Trial Monitoring

This peer-reviewed article reviews the PUEKS project, which has devoted two years to the evaluation and optimization of RBM.

 

Adoption of RBQM in Academic Settings

This article provides the lessons learned as the biopharmaceutical industry explores Risk-Based Monitoring (RBM) as a part of Risk-Based Quality Management (RBQM).


Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription

Get the full picture


Ask the editor

Lisa Henderson
Editor in Chief
[email protected]

Advertise

Mike Tessalone
Publisher
[email protected]